Evidence map›Paper›PMID 29069071›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Clinical Significance of Routine Blood Test-Associated Inflammatory Index in Breast Cancer Patients.

Hong Sun, Chang-Qing Yin, Qing Liu, Fubing Wang, Chun-Hui Yuan

Open access · bronzeAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Platelet Indices as a Biomarker in Distinguishing Benign and Malignant Breast Lesions.Asian Pacific journal of cancer prevention : APJCP · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. BaselineLa Radiologia medica · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hong SunDepartment of Laboratory Medicine, Wuhan Children's Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland).
Chang-Qing YinDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Qing LiuDepartment of Oncology, Zhongnan Hospital of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Fubing WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Chun-Hui YuanDepartment of Laboratory Medicine, Wuhan Children's Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland).
Huazhong University of Science and Technology · CNZhongnan Hospital of Wuhan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND It is now widely acknowledged that chronic inflammation is closely associated with the process of cancer development. As a simple noninvasive blood-based test, hematological parameters in the routine blood test have been considered as inflammation markers. We aimed to evaluate platelet count (PC), red blood cell distribution width (RDW), white blood cell count (WBC), mean platelet volume (MPV), number of neutrophils/lymphocytes ratio (NLR), and platelet count/lymphocytes ratio (PLR) as surrogate inflammatory markers in breast cancer (BC) patients, and we compared these to those in healthy individuals. MATERIAL AND METHODS A retrospective study was conducted in Zhongnan Hospital of Wuhan University from July 2014 to April 2015, including 110 cases of pathologically diagnosed BC patients and 78 cases of healthy females. Retrospective analysis of selected hematological parameters was performed between the 2 groups, as well as assessment of the correlation between these indexes and clinicopathological characteristics of the 110 breast cancer patients. RESULTS The mean values of RDW, MPV, NLR, and PLR were significantly higher in BC patients compared to the control group. The level of MPV exhibited positive correlations with lymph node metastasis and the Ki67 proliferation index in preoperative BC patients (P<0.05). Logistic regression analysis further showed that MPV was independently associated with the risk of BC lymph node metastasis (P<0.05). CONCLUSIONS Hematological parameters of RDW, MPV, NLR, and PLR can be used as an adjuvant tool for the diagnosis of BC. More importantly, the value of MPV can reflect the Ki67 proliferation index before surgery and identify patients with positive lymph node metastasis.

Indexed as

Diagnostic Tests, RoutineHematologic TestsBreast NeoplasmsCase-Control StudiesDemographyFemaleHumansInflammationLogistic ModelsLymphocyte CountLymphocytesMean Platelet VolumeMiddle AgedMultivariate AnalysisNeutrophilsPlatelet Count

Identifiers

PMID29069071
PMCPMC5667583
OpenAlexW2765927956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.